{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:25:38Z","timestamp":1790825138747,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Jiangsu Province basic research project of Natural Science Foundation","award":["BK20131327"],"award-info":[{"award-number":["BK20131327"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-1117-9","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T04:39:19Z","timestamp":1542861559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Significance of histological crescent formation in patients with IgA vasculitis (Henoch-Sch\u00f6nlein purpura)-related nephritis: a cohort in the adult Chinese population"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-mei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-xin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-hong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8899-0077","authenticated-orcid":false,"given":"Zheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,22]]},"reference":[{"key":"1117_CR1","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S0140-6736(07)60474-7","volume":"369","author":"FT Saulsbury","year":"2007","unstructured":"Saulsbury FT. Clinical update: Henoch-Schonlein purpura. Lancet. 2007;369:976\u20138.","journal-title":"Lancet"},{"key":"1117_CR2","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1136\/adc.2005.074641","volume":"90","author":"H Narchi","year":"2005","unstructured":"Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child. 2005;90:916\u201320.","journal-title":"Arch Dis Child"},{"key":"1117_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2215\/CJN.06710810","volume":"6","author":"JC Davin","year":"2011","unstructured":"Davin JC. Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy. Clin J Am Soc Nephrol. 2011;6:679\u201389.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1117_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5415\/apallergy.2014.4.1.42","volume":"4","author":"R Ghrahani","year":"2014","unstructured":"Ghrahani R, Ledika MA, Sapartini G, Setiabudiawan B. Age of onset as a risk factor of renal involvement in Henoch-Schonlein purpura. Asia Pac Allergy. 2014;4:42\u20137.","journal-title":"Asia Pac Allergy"},{"key":"1117_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/pr.2015.271","volume":"79","author":"AC Chen","year":"2016","unstructured":"Chen AC, Lin CL, Shen TC, Li TC, Sung FC, Wei CC. Association between allergic diseases and risks of HSP and HSP nephritis: a population-based study. Pediatr Res. 2016;79:559\u201364.","journal-title":"Pediatr Res"},{"key":"1117_CR6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/kisup.2012.24","volume":"2","author":"Kidney Disease: Improving global outcomes","year":"2012","unstructured":"Kidney Disease: Improving global outcomes. Chapter 11: Henoch-Schonlein purpura nephritis. Kidney Int Suppl (2011). 2012;2:218\u201320.","journal-title":"Kidney Int Suppl (2011)"},{"key":"1117_CR7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/01.ASN.0000013883.99976.22","volume":"13","author":"E Pillebout","year":"2002","unstructured":"Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schonlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002;13:1271\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"1117_CR8","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1053\/j.ajkd.2006.02.178","volume":"47","author":"R Coppo","year":"2006","unstructured":"Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, et al. Predictors of outcome in Henoch-Schonlein nephritis in children and adults. Am J Kidney Dis. 2006;47:993\u20131003.","journal-title":"Am J Kidney Dis"},{"key":"1117_CR9","doi-asserted-by":"publisher","first-page":"e0127767","DOI":"10.1371\/journal.pone.0127767","volume":"10","author":"Q Ye","year":"2015","unstructured":"Ye Q, Shang SQ, Liu AM, Zhang T, Shen HQ, Chen XJ, et al. 24h urinary protein levels and urine protein\/creatinine ratios could probably forecast the pathological classification of HSPN. PLoS One. 2015;10:e0127767.","journal-title":"PLoS One"},{"key":"1117_CR10","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s00467-010-1444-y","volume":"25","author":"S Edstrom Halling","year":"2010","unstructured":"Edstrom Halling S, Soderberg MP, Berg UB. Predictors of outcome in Henoch-Schonlein nephritis. Pediatr Nephrol. 2010;25:1101\u20138.","journal-title":"Pediatr Nephrol"},{"key":"1117_CR11","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00467-007-0557-4","volume":"22","author":"M Shenoy","year":"2007","unstructured":"Shenoy M, Bradbury MG, Lewis MA, Webb NJ. Outcome of Henoch-Schonlein purpura nephritis treated with long-term immunosuppression. Pediatr Nephrol. 2007;22:1717\u201322.","journal-title":"Pediatr Nephrol"},{"key":"1117_CR12","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ki.2012.302","volume":"82","author":"HJ Oh","year":"2012","unstructured":"Oh HJ, Ahn SV, Yoo DE, Kim SJ, Shin DH, Lee MJ, et al. Clinical outcomes, when matched at presentation, do not vary between adult-onset Henoch-Schonlein purpura nephritis and IgA nephropathy. Kidney Int. 2012;82:1304\u201312.","journal-title":"Kidney Int"},{"key":"1117_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00467-014-3016-z","volume":"30","author":"S Lu","year":"2015","unstructured":"Lu S, Liu D, Xiao J, Yuan W, Wang X, Zhang X, et al. Comparison between adults and children with Henoch-Schonlein purpura nephritis. Pediatr Nephrol. 2015;30:791\u20136.","journal-title":"Pediatr Nephrol"},{"key":"1117_CR14","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1046\/j.1523-1755.2003.00843.x","volume":"63","author":"JC Jennette","year":"2003","unstructured":"Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63:1164\u201377.","journal-title":"Kidney Int"},{"key":"1117_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/qjmed\/hcl034","volume":"99","author":"S Shrestha","year":"2006","unstructured":"Shrestha S, Sumingan N, Tan J, Alhous H, McWilliam L, Ballardie F. Henoch Schonlein purpura with nephritis in adults: adverse prognostic indicators in a UK population. QJM. 2006;99:253\u201365.","journal-title":"QJM"},{"key":"1117_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5414\/CNP58001","volume":"58","author":"V Rauta","year":"2002","unstructured":"Rauta V, Tornroth T, Gronhagen-Riska C. Henoch-Schoenlein nephritis in adults-clinical features and outcomes in Finnish patients. Clin Nephrol. 2002;58:1\u20138.","journal-title":"Clin Nephrol"},{"key":"1117_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/MD.0000000000000019","volume":"93","author":"V Calvo-Rio","year":"2014","unstructured":"Calvo-Rio V, Loricera J, Mata C, Martin L, Ortiz-Sanjuan F, Alvarez L, et al. Henoch-Schonlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center. Medicine (Baltimore). 2014;93:106\u201313.","journal-title":"Medicine (Baltimore)"},{"key":"1117_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00005792-200109000-00001","volume":"80","author":"MC Calvino","year":"2001","unstructured":"Calvino MC, Llorca J, Garcia-Porrua C, Fernandez-Iglesias JL, Rodriguez-Ledo P, Gonzalez-Gay MA. Henoch-Schonlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine (Baltimore). 2001;80:279\u201390.","journal-title":"Medicine (Baltimore)"},{"key":"1117_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1\u201311.","journal-title":"Arthritis Rheum"},{"key":"1117_CR20","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/art.1780330809","volume":"33","author":"JA Mills","year":"1990","unstructured":"Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum. 1990;33:1114\u201321.","journal-title":"Arthritis Rheum"},{"key":"1117_CR21","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/ndt\/gfr527","volume":"27","author":"W Le","year":"2012","unstructured":"Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, et al. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant. 2012;27:1479\u201385.","journal-title":"Nephrol Dial Transplant"},{"key":"1117_CR22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/0140-6736(92)91341-5","volume":"339","author":"AR Goldstein","year":"1992","unstructured":"Goldstein AR, White RH, Akuse R, Chantler C. Long-term follow-up of childhood Henoch-Schonlein nephritis. Lancet. 1992;339:280\u20132.","journal-title":"Lancet"},{"key":"1117_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1875-9572(09)60056-5","volume":"50","author":"SP Hung","year":"2009","unstructured":"Hung SP, Yang YH, Lin YT, Wang LC, Lee JH, Chiang BL. Clinical manifestations and outcomes of Henoch-Schonlein purpura: comparison between adults and children. Pediatr Neonatol. 2009;50:162\u20138.","journal-title":"Pediatr Neonatol"},{"key":"1117_CR24","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/modpathol.2013.222","volume":"27","author":"CH Kim","year":"2014","unstructured":"Kim CH, Lim BJ, Bae YS, Kwon YE, Kim YL, Nam KH, et al. Using the Oxford classification of IgA nephropathy to predict long-term outcomes of Henoch-Schonlein purpura nephritis in adults. Mod Pathol. 2014;27:972\u201382.","journal-title":"Mod Pathol"},{"key":"1117_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ki.1983.32","volume":"23","author":"WM Bennett","year":"1983","unstructured":"Bennett WM, Kincaid-Smith P. Macroscopic hematuria in mesangial IgA nephropathy: correlation with glomerular crescents and renal dysfunction. Kidney Int. 1983;23:393\u2013400.","journal-title":"Kidney Int"},{"key":"1117_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s40620-014-0165-x","volume":"28","author":"XH Shen","year":"2015","unstructured":"Shen XH, Liang SS, Chen HM, Le WB, Jiang S, Zeng CH, et al. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation. J Nephrol. 2015;28:441\u20139.","journal-title":"J Nephrol"},{"key":"1117_CR27","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1067\/mpd.2000.103448","volume":"136","author":"BJ Foster","year":"2000","unstructured":"Foster BJ, Bernard C, Drummond KN, Sharma AK. Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr. 2000;136:370\u20135.","journal-title":"J Pediatr"},{"key":"1117_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000046235","volume":"21","author":"JT Flynn","year":"2001","unstructured":"Flynn JT, Smoyer WE, Bunchman TE, Kershaw DB, Sedman AB. Treatment of Henoch-Schonlein Purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide. Am J Nephrol. 2001;21:128\u201333.","journal-title":"Am J Nephrol"},{"key":"1117_CR29","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00467-005-1864-2","volume":"20","author":"JI Shin","year":"2005","unstructured":"Shin JI, Park JM, Shin YH, Kim JH, Kim PK, Lee JS, et al. Cyclosporin a therapy for severe Henoch-Schonlein nephritis with nephrotic syndrome. Pediatr Nephrol. 2005;20:1093\u20137.","journal-title":"Pediatr Nephrol"},{"key":"1117_CR30","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s00467-011-1919-5","volume":"26","author":"O Jauhola","year":"2011","unstructured":"Jauhola O, Ronkainen J, Autio-Harmainen H, Koskimies O, Ala-Houhala M, Arikoski P, et al. Cyclosporine a vs. methylprednisolone for Henoch-Schonlein nephritis: a randomized trial. Pediatr Nephrol. 2011;26:2159\u201366.","journal-title":"Pediatr Nephrol"},{"key":"1117_CR31","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s00467-004-1514-0","volume":"19","author":"Y Kawasaki","year":"2004","unstructured":"Kawasaki Y, Suzuki J, Murai M, Takahashi A, Isome M, Nozawa R, et al. Plasmapheresis therapy for rapidly progressive Henoch-Schonlein nephritis. Pediatr Nephrol. 2004;19:920\u20133.","journal-title":"Pediatr Nephrol"},{"key":"1117_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/art.40339","volume":"70","author":"F Maritati","year":"2018","unstructured":"Maritati F, Fenoglio R, Pillebout E, Emmi G, Urban ML, Rocco R, et al. Brief Report: Rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Sch\u00f6nlein purpura). Arthritis Rheumatol. 2018;70:109\u2013114.","journal-title":"Arthritis Rheumatol."},{"key":"1117_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ki.2010.150","volume":"78","author":"E Pillebout","year":"2010","unstructured":"Pillebout E, Alberti C, Guillevin L, Ouslimani A, Thervet E. Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schonlein Purpura. Kidney Int. 2010;78:495\u2013502.","journal-title":"Kidney Int"},{"key":"1117_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jpeds.2006.03.024","volume":"149","author":"J Ronkainen","year":"2006","unstructured":"Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, et al. Early prednisone therapy in Henoch-Schonlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2006;149:241\u20137.","journal-title":"J Pediatr"},{"key":"1117_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00467-003-1315-x","volume":"19","author":"P Tarshish","year":"2004","unstructured":"Tarshish P, Bernstein J, Edelmann CM Jr. Henoch-Schonlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatr Nephrol. 2004;19:51\u20136.","journal-title":"Pediatr Nephrol"},{"key":"1117_CR36","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/adc.2009.167874","volume":"95","author":"O Jauhola","year":"2010","unstructured":"Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, et al. Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study. Arch Dis Child. 2010;95:871\u20136.","journal-title":"Arch Dis Child"},{"key":"1117_CR37","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jama.2017.9362","volume":"318","author":"J Lv","year":"2017","unstructured":"Lv J, Zhang H, Wong MG, Jardine MJ, Hladunewich M, Jha V, et al. Effect of Oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA. 2017;318:432\u201342.","journal-title":"JAMA"},{"key":"1117_CR38","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1093\/ndt\/12.11.2277","volume":"12","author":"R Coppo","year":"1997","unstructured":"Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP. Long-term prognosis of Henoch-Schonlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schonlein purpura. Nephrol Dial Transplant. 1997;12:2277\u201383.","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1117-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-1117-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1117-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T19:08:14Z","timestamp":1574363294000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-1117-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,22]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1117"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-1117-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,22]]},"assertion":[{"value":"24 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol followed in the present study was approved by the Jinling Hospital Ethics Committee on Human Experimentation. Due to the retrospective nature of the study, written informed consent for participation in the study was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"334"}}